We are live on
!
Find out more
TCM
Towercrest Capital Management Portfolio holdings
AUM
$642M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$608M
AUM Growth
+$14.7M
(+2.5%)
Cap. Flow
+$8.31M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
51.61%
Holding
111
New
4
Increased
38
Reduced
35
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.77M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.14M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$1.61M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.58M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$1.34M |
| 2 |
Schwab U.S Small- Cap ETF
SCHA
|
+$953K |
| 3 |
iShares Biotechnology ETF
IBB
|
+$728K |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$479K |
| 5 |
Apple
AAPL
|
+$388K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.57% |
| 2 | Communication Services | 0.91% |
| 3 | Healthcare | 0.59% |
| 4 | Financials | 0.58% |
| 5 | Industrials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $240K | 0.04% |
8,328
+377
| +5% | +$11.2K |
|
102
Vanguard High Dividend Yield ETF
VYM
$81B
| $227K | 0.04% |
+1,915
| New | +$227K |
|
103
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.3B
| $218K | 0.04% |
+3,475
| New | +$203K |
|
104
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $217K | 0.04% |
3,702
-199
| -5% | -$11.7K |
|
105
Consolidated Edison
ED
$40.1B
| $212K | 0.03% |
2,374
| – | – |
|
106
Berkshire Hathaway Class B
BRK.B
$1.1T
| $208K | 0.03% |
512
| – | – |
|
107
Hershey
HSY
$35.5B
| $202K | 0.03% |
1,100
| – | – |
|
108
Bristol-Myers Squibb
BMY
$133B
| – | – |
-4,505
| Closed | -$244K |
|
109
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
| – | – |
-2,601
| Closed | -$248K |
|
|
110
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| – | – |
-5,050
| Closed | -$479K |
|
111
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| – | – |
-5,411
| Closed | -$228K |
|
Similar funds
APC
RR
GECH
WHGAM
PCM
CRCM
SFG
SCP
Towercrest Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Towercrest Capital Management held 111 positions worth $608M, up 2.5% from $593M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Towercrest Capital Management's Q2 2024 filing shows 4 new, 38 increased, 35 reduced and 4 closed positions. Its largest new stake was Matinas BioPharma: 37,734 shares worth $299K. The largest sale was Schwab US Large- Cap ETF, an estimated $1.34M.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.2% a quarter earlier, followed by Communication Services and Healthcare.
- Towercrest Capital Management's largest Q2 2024 buy was Matinas BioPharma: 37,734 shares worth $299K.
- Towercrest Capital Management added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $2.77M increase.
- Towercrest Capital Management's biggest Q2 2024 reduction was Schwab US Large- Cap ETF, cutting an estimated $1.34M.
- Towercrest Capital Management fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $479K.
- Towercrest Capital Management's ten largest holdings make up 52% of its $608M portfolio in Q2 2024.
- Towercrest Capital Management opened 4 new positions and closed 4 in Q2 2024.
- Towercrest Capital Management's portfolio value rose 2.5% quarter-over-quarter to $608M.
Based on Towercrest Capital Management's 13F filing for Q2 2024, filed 6 Aug 2024.